Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2017 09:00 ET | Source: AbCellera

AbCellera Announces Expanded Research Collaboration with Teva

VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Teva Pharmaceutical Industries, Ltd....
June 06, 2017 09:00 ET | Source: AbCellera

AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research

VANCOUVER, British Columbia, June 06, 2017 (GLOBE NEWSWIRE) -- AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines...
January 19, 2017 09:00 ET | Source: AbCellera

AbCellera Receives Grant to Help Fight Tuberculosis

AbCellera received a grant from the Bill & Melinda Gates Foundation to discover antibodies against Mycobacterium tuberculosis.VANCOUVER, British Columbia, Jan. 19, 2017 (GLOBE NEWSWIRE) --...
January 05, 2017 09:00 ET | Source: AbCellera

AbCellera Announces Multi-Target Research Collaboration with Pfizer

VANCOUVER, British Columbia, Jan. 05, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Pfizer Inc. (NYSE:PFE). AbCellera...
August 24, 2016 09:00 ET | Source: AbCellera

AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates

VANCOUVER, British Columbia, Aug. 24, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...
July 20, 2016 09:00 ET | Source: AbCellera

AbCellera and MassBiologics Partner to Discover Fully Human Antibodies Against Drug-Resistant Bacteria

VANCOUVER, British Columbia, July 20, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...
February 02, 2016 08:00 ET | Source: AbCellera

Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies

JERUSALEM and VANCOUVER, British Columbia, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and AbCellera have entered into a collaborative research...
January 27, 2016 16:08 ET | Source: AbCellera

AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration

VANCOUVER, British Columbia, Jan. 27, 2016 (GLOBE NEWSWIRE) -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today...
January 20, 2016 19:13 ET | Source: AbCellera

AbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola Virus

VANCOUVER, British Columbia, Jan. 20, 2016 (GLOBE NEWSWIRE) -- AbCellera announced today successful completion of its first antibody discovery partnership with MassBiologics of the University...